干细胞领域知识发现平台

提升科研信息化水平
支撑研究所科技创新

  融合多源信息    打通数据孤岛
  挖掘知识关联    放大数据价值
  集成知识计算    促进知识发现

Chris Mason     英国

University College London

男    博士    【研究领域】干细胞与再生医学生物机制研究


2
专利
11
论文
0
项目
5
资讯

H指数

专家简介

Professor Chris Mason is internationally recognised to be at the forefront of the emerging fields of cell therapy and regenerative medicine translation and commercialization. A background in basic science, clinical medicine, bioprocessing and business allows Chris a unique insight and understanding of the challenges facing the cell-based therapy sector as it grows into a competitive and sustainable global healthcare industry. Chris holds a Clinical Sciences degree from Imperial College London, a Medical degree from the United Medical and Dental Schools of Guy’s and St. Thomas’s Hospitals (now King’s College London) and a PhD under the supervision of Prof. Peter Dunnill in tissue-engineering bioprocessing from University College London. Chris is on a number of national and international committees, working groups and initiatives related to the academic, clinical and commercial advancement of cell-based therapies and tissue engineering including; Chair of the BIA Cell Therapy & Regenerative Medicine Industry Group and member of the ISSCR Industry Committee, the Alliance for Regenerative Medicine (ARM) Communication & Education Committee and ISCT Commercialization Committee. In May 2012, he became the first President of The Regenerative Medicine Coalition. He is a Senior Partner at Proteus Venture Partners, has a broad range of expertise in commercial consultancy and is on the Scientific Advisory Boards of a number of companies.

发表专利

专利名称 专利公开号
CELL PURIFICATION WO2009030944A1
Cell Purification WO_2009_030944_A1

研究方向

这是标签2的内容。